Gwendolyn R Cody1, Binhuan Wang2, Alissa R Link2, Scott E Sherman2,3,4. 1. a New York University School of Medicine , New York USA. 2. b Department of Population Health , New York University School of Medicine , New York. 3. c Department of Medicine , VA New York Harbor Healthcare System , New York , USA. 4. d Department of Medicine , New York University School of Medicine , New York , USA.
Abstract
BACKGROUND:Cigarette smoking and chronic pain are prevalent, comorbid conditions with significant consequences for individuals and society. Despite overlap between smoking and chronic pain, and pain's role as a potential barrier to quitting, there are no validated interventions targeted for smokers with chronic pains (SWCPs). OBJECTIVE: To compare characteristics of urban inpatient smokers with and without chronic pain to inform the development of SWCP-targeted cessation interventions. METHODS: This study reports partial results from a randomized comparative effectiveness trial of two smoking cessation interventions (NCT01363245). Participants were enrolled at two safety net hospitals in New York, NY in 2011-2014. Data were collected from the electronic health record and an interviewer-administered survey. Participants were considered to have chronic pain if they affirmed having "long-lasting, persistent, or chronic pain in the last six months" on survey. RESULTS: Among smokers assessed for pain (n = 1093), the prevalence of chronic pain was 44%. SWCPs were more likely to report depressive symptoms and to have a history of psychiatric diagnosis (nonsubstance related) than smokers without pain. Severe problems with mobility and with performing usual activities were more common in SWCPs. No significant difference was observed in sex, race, education, nicotine dependence level, confidence in quit ability, or history of substance misuse. Conclusions/Importance: Chronic pain in smokers admitted to safety net hospitals is prevalent and associated with hindered mobility, history of psychiatric diagnosis, and prescription opioid use. Urban safety net hospitals are an appropriate setting in which to pilot SWCP-targeted cessation programs, which should be designed with consideration for patients' psychiatric history and mobility status.
RCT Entities:
BACKGROUND: Cigarette smoking and chronic pain are prevalent, comorbid conditions with significant consequences for individuals and society. Despite overlap between smoking and chronic pain, and pain's role as a potential barrier to quitting, there are no validated interventions targeted for smokers with chronic pains (SWCPs). OBJECTIVE: To compare characteristics of urban inpatient smokers with and without chronic pain to inform the development of SWCP-targeted cessation interventions. METHODS: This study reports partial results from a randomized comparative effectiveness trial of two smoking cessation interventions (NCT01363245). Participants were enrolled at two safety net hospitals in New York, NY in 2011-2014. Data were collected from the electronic health record and an interviewer-administered survey. Participants were considered to have chronic pain if they affirmed having "long-lasting, persistent, or chronic pain in the last six months" on survey. RESULTS: Among smokers assessed for pain (n = 1093), the prevalence of chronic pain was 44%. SWCPs were more likely to report depressive symptoms and to have a history of psychiatric diagnosis (nonsubstance related) than smokers without pain. Severe problems with mobility and with performing usual activities were more common in SWCPs. No significant difference was observed in sex, race, education, nicotine dependence level, confidence in quit ability, or history of substance misuse. Conclusions/Importance: Chronic pain in smokers admitted to safety net hospitals is prevalent and associated with hindered mobility, history of psychiatric diagnosis, and prescription opioid use. Urban safety net hospitals are an appropriate setting in which to pilot SWCP-targeted cessation programs, which should be designed with consideration for patients' psychiatric history and mobility status.
Authors: W Michael Hooten; Cynthia O Townsend; J Taylor Hays; Kaye L Ebnet; Thomas R Gauvin; Jessica M Gehin; Heidi J Laures; Christi A Patten; David O Warner Journal: Addict Behav Date: 2013-11-21 Impact factor: 3.913
Authors: S D Passik; K L Kirsh; M V McDonald; S Ahn; S M Russak; L Martin; B Rosenfeld; W S Breitbart; R K Portenoy Journal: J Pain Symptom Manage Date: 2000-04 Impact factor: 3.612
Authors: W Michael Hooten; Cynthia O Townsend; Barbara K Bruce; John E Schmidt; Jennifer L Kerkvliet; Christi A Patten; David O Warner Journal: Pain Med Date: 2008-08-18 Impact factor: 3.750
Authors: O van Hecke; N Torrance; L Cochrane; J Cavanagh; P T Donnan; S Padmanabhan; D J Porteous; L Hocking; B H Smith Journal: Eur J Pain Date: 2014-02-27 Impact factor: 3.931
Authors: Ellie Grossman; Donna Shelley; R Scott Braithwaite; Iryna Lobach; Ana Goffin; Erin Rogers; Scott Sherman Journal: Trials Date: 2012-08-01 Impact factor: 2.279
Authors: Leslie W Suen; Vanessa M McMahan; Christopher Rowe; Sumeet Bhardwaj; Kelly Knight; Margot B Kushel; Glenn-Milo Santos; Phillip Coffin Journal: J Am Board Fam Med Date: 2021 Nov-Dec Impact factor: 2.395
Authors: Lori A Bastian; Mary Driscoll; Eric DeRycke; Sara Edmond; Kristin Mattocks; Joe Goulet; Robert D Kerns; Mark Lawless; Caroline Quon; Kim Selander; Jennifer Snow; Jose Casares; Megan Lee; Cynthia Brandt; Joseph Ditre; William Becker Journal: Contemp Clin Trials Commun Date: 2021-08-20